In animal models of neurodegenerative diseases, the JAK–STAT signaling pathway was activated in reactive astrocytes, and inhibition of the JAK–STAT signaling blocked astrocyte reactivity and reduced neuronal damage [54,55]. This evidence concerns the gene SOAT1 and neurodegenerative disease.